Trial Profile
Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Triheptanoin (Primary)
- Indications Rett syndrome
- Focus Adverse reactions
- 03 Mar 2017 New trial record